Filing Details
- Accession Number:
- 0001077183-18-000019
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-05-10 17:53:07
- Reporting Period:
- 2018-05-10
- Accepted Time:
- 2018-05-10 17:53:07
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1077183 | Neogenomics Inc | NEO | Services-Testing Laboratories (8734) | 742897368 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1591976 | A Steven Ross | 12701 Commonwealth Drive Suite 9 Fort Myers FL 33913 | Cio | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2018-05-10 | 33,667 | $4.78 | 38,167 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2018-05-10 | 26,666 | $7.15 | 64,833 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2018-05-10 | 21,666 | $7.52 | 86,499 | No | 4 | M | Direct | |
Common Stock | Disposition | 2018-05-10 | 81,999 | $10.78 | 4,500 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2018-05-10 | 33,667 | $4.78 | 33,667 | $4.78 |
Common Stock | Stock Option (Right to Buy) | Disposition | 2018-05-10 | 26,666 | $7.15 | 26,666 | $7.15 |
Common Stock | Stock Option (Right to Buy) | Disposition | 2018-05-10 | 21,666 | $7.52 | 21,666 | $7.52 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2016-05-06 | 2020-05-06 | No | 4 | X | Direct |
13,334 | 2017-04-20 | 2021-04-20 | No | 4 | X | Direct |
43,334 | 2018-04-28 | 2022-04-28 | No | 4 | X | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 4,500 | Direct |
Reported Derivative Holdings
Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | $8.03 | 2019-02-26 | 2023-02-26 | 72,500 | 72,500 | Direct |
Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|
2023-02-26 | 72,500 | 72,500 | Direct |
Footnotes
- On April 20, 2016, Mr. Ross was granted 40,000 stock options. These options vest ratably over the first three anniversary dates of the grant date. Mr. Ross exercised 26,666 of these options in May 2018, leaving a balance of 13,334 options.
- On April 28, 2017, Mr. Ross was granted 65,000 stock options. These options vest ratably over the first three anniversary dates of the grant date. Mr. Ross exercised 21,666 of these options in May 2018, leaving a balance of 43,334 options.
- On February 26, 2018, Mr. Ross was granted 72,500 stock options. These options vest ratably over the first three anniversary dates of the grant date.